Skip to main content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication

Minutes of Proceedings

42nd Parliament, 1st Session
Meeting No. 22
Tuesday, October 4, 2016, 8:47 a.m. to 10:47 a.m.
Len Webber, Vice-Chair (Conservative)

Library of Parliament
• Karin Phillips, Analyst
• Marlisa Tiedemann, Analyst
Department of Health
• Hilary Geller, Assistant Deputy Minister, Healthy Environments and Consumer Safety Branch
• Supriya Sharma, Senior Medical Advisor, Health Products and Food Branch
Canadian Institute for Health Information
• Brent Diverty, Vice President, Programs
Royal Canadian Mounted Police
• Todd G. Shean, Assistant Commissioner, Federal Policing Special Services
• Luc Chicoine, National Drug Coordinator, Federal Coordination Centre, Federal and International Support Services
Canada Border Services Agency
• Caroline Xavier, Vice President, Operations Branch
Canadian Centre on Substance Abuse
• Rita Notarandrea, Chief Executive Officer
• Matthew Young, Senior Research and Policy Analyst
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on September 22, 2016, the Committee commenced its study of the Opioid Crisis in Canada.

Hilary Geller, Todd G. Shean, Caroline Xavier and Rita Notarandrea made statements and, with Supriya Sharma and Matthew Young, answered questions.

Sonia Sidhu gave notice of the following motion:

That, pursuant to Standing Order 108(2), the Committee call upon the Minister of Health to move as quickly as possible to conduct a review of the laws and regulations in place with regard to safe injection sites; and that this review have as an end goal to improve the health and safety of Canadians, using a strong, evidence-based approach.

At 10:47 a.m., the Committee adjourned to the call of the Chair.

David Gagnon
Clerk of the Committee